- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02435667
Resistance Training in HFpEF
Resistance Exercise Training in Heart Failure With Preserved Ejection Fraction (Resist - HFpEF)
Study Overview
Status
Conditions
Detailed Description
In this randomized controlled pilot study of resistance exercise training in patients with HFpEF, the investigators will recruit 24 HFpEF patients who will be randomized to resistance exercise training (RT - n=12) or no resistance exercise training (standard care control group [CTL] - n=12). The investigators will have baseline and follow-up measures of clinical characteristics, leg muscle strength, quality of life, lean muscle mass (body composition via DXA including segmental lean mass), maximal cardiopulmonary exercise test (peak VO2, peak work, ventilatory efficiency), constant-load submaximal cardiopulmonary exercise test with speckle tracking echocardiography (exertional dyspnea and fatigue at matched workloads, cardiac output, diastolic function, left ventricular strain, ventilation, gas exchange, and locomotor muscle neural feedback).
Participants will be asked to make 4 separate study visits. Those randomized to undergo Resistance Training will be expected to make those visits as well.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
All patients will be managed by their primary care physician or cardiologist with additional review and oversight by Dr. Borlaug (Co-Investigator) prior to enrollment to ensure adequacy of inclusion and exclusion criteria and that participation in exercise testing and resistance exercise training is safe.
Inclusion Criteria, includes:
- Clinical diagnosis of HFpEF.
- Patients 18-80 yrs old with a history stable (no medication changes in past 6 weeks (w/duration of diagnosis >6 months).
- New York Heart Association class I-III.
- Ejection fraction ≥40%.
- Current non-smokers with <15 pack year history.
- Non-pregnant women, and individuals who are able to exercise (i.e. without orthopedic limitations or neuromuscular disorders).
Exclusion Criteria, includes:
- Patient refusal to participate.
- Significant orthopedic or neuromuscular limitations
- Significant cognitive impairment
- Hemoglobin < 7.0 g/d.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Resistance Exercise Training
Entails 36 supervised resistance exercise training sessions (3 sessions per week for 12 weeks).
Each exercise session will be supervised by a trained, certified Exercise Physiologist specializing in Cardiac Rehabilitation.
The specific resistance exercise training will include Aerobic Exercise, Resistance Exercise, and Core Strengthening Exercises.
Other baseline and follow-up tests include: DEXA bone scan, Blood Draw, Cardiopulmonary Max Exercise Test, Quality of Life Questionnaire, and a Submaximal Exercise Test.
|
A DEXA scan that provides bone density measures.
Pedaling on a cycle ergometer to volitional fatigue.
A 10 minute questionnaire that measures quality of life.
Two short submaximal constant-load exercise sessions at 20 Watts.
Each session will include 6 minutes of cycling (baseline).
Following baseline, the sessions will be randomized to continued constant-load cycling for an additional 9 minutes (for echocardiographic measures) or randomized sub-systolic inflation of bilateral thigh pressure tourniquets to 40 and 80 mmHg for 3 minutes with 3 minutes of deflation between inflations to stimulate locomotor muscle neural feedback.
A blood draw amounting to 1 teaspoon of blood drawn.
|
|
Placebo Comparator: Standard Care
No resistance exercise training.
Patients will stay on their current healthcare regimen as previously assigned by their physician.
Patients will still undergo baseline and follow-up tests similar to the Resistance Exercise Training group, including: DEXA bone scan, Blood Draw, Cardiopulmonary Max Exercise Test, Quality of Life Questionnaire, and a Submaximal Exercise Test.
|
A DEXA scan that provides bone density measures.
Pedaling on a cycle ergometer to volitional fatigue.
A 10 minute questionnaire that measures quality of life.
Two short submaximal constant-load exercise sessions at 20 Watts.
Each session will include 6 minutes of cycling (baseline).
Following baseline, the sessions will be randomized to continued constant-load cycling for an additional 9 minutes (for echocardiographic measures) or randomized sub-systolic inflation of bilateral thigh pressure tourniquets to 40 and 80 mmHg for 3 minutes with 3 minutes of deflation between inflations to stimulate locomotor muscle neural feedback.
A blood draw amounting to 1 teaspoon of blood drawn.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone density and strength
Time Frame: 12 weeks
|
DEXA scan
|
12 weeks
|
|
Cardiopulmonary Function
Time Frame: 12 weeks
|
Cardiopulmonary bike exercise
|
12 weeks
|
|
Quality of Life
Time Frame: 12 weeks
|
Questionnaire
|
12 weeks
|
|
Blood Biomarkers
Time Frame: 12 weeks
|
Blood draw
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas Olson, MS, PhD, Mayo Clinic
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-000320
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.